Kick-start for Canada's agbio
News Nov 09, 2009
John Hodgson, Nature Biotechnology 27, 970 - 2009
Bioenterprise Capital will
be run by experienced entrepreneurs and investors rather than bankers,
says Dave Smardon, president and CEO of BioEnterprise Corp of Guelph,
Ontario, Canada, one of the entrepreneurs involved. "There were 173
venture capital and angel investor groups active in Canada in 2001," he
says, "but there are now only 30."
Furthermore, virtually all the capital has migrated towards investment in late-stage, lower-risk companies, in information technology, telecommunications and medical applications. The fund managers will take an extremely hands-on approach to their investments, a form of "quasi-incubation" according to Smardon.
To date, over 40 industry and investment mentors have
joined the cause. "The presence of people who know how to make
companies succeed means that we're not picking winners, we are building
winners," says Smardon. The fund is expected to close in September
2010, with money coming from private investors, government agencies and
Approximately half will come from within Canada, and half from international sources. Government participation is expected to be below 20% of the fund's total. One private investment group has already stepped up with a CAD$25 million ($24.3 million) cornerstone.
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE
Genetics Help Make a Weed a WeedNews
A study has has found that the success of weedy and invasive plants like the Jerusalem artichoke lies in their genes. Understanding how invasive plants evolve and the genes that enable them to thrive in a new environment is key to better understanding why they are wreaking havoc on natural landscapes and food production around the world.READ MORE